by Lab Admin | Aug 10, 2026 | Blog, More Info
Subject: Important Regulatory Update: Testing Availability for MGM-15, MGM-16, and Mitragynine Pseudoindoxyl — 1. The Federal Regulatory Status (Clarification) July 6, 2026 (Notice of Intent): The U.S. Drug Enforcement Administration (DEA) published a formal...
by Lab Admin | Aug 5, 2026 | Blog, More Info
How to Track Real-Time Kratom Regulatory Updates: Federal Register & Florida Compliance Portals In an era of rapid emergency rulemaking, staying ahead of regulatory changes is an operational necessity for quality assurance managers, analytical laboratories,...
by Lab Admin | Aug 5, 2026 | Blog, More Info
Florida’s Emergency Kratom Regulations: Rules 2ER26-1, 5KER26-9, and the Analytical CRM Bottleneck Florida has established itself as one of the most aggressive state regulatory environments for botanical supplements and novel alkaloid products. Through joint action...
by Lab Admin | Aug 5, 2026 | Blog, More Info
The Federal 7-OH Temporary Scheduling Order: DEA Docket DEA-1570, Concentration Thresholds, and Laboratory Compliance The regulatory landscape for Mitragyna speciosa and its derived alkaloids has reached a historical turning point. Following months of heightened...
by Lab Admin | Aug 1, 2026 | Blog, More Info, Quantify
Clients, Wonderland Labs unintentionally placed a phrase on our recent COAs that may have implied a scientific opinion that we do not possess. Instead of including the full chemical name after the MGM-15 table entry, we included a Google result of “MGM-15...
by Lab Admin | Jan 5, 2026 | Blog, Identify, More Info, Testing Services
Wonderland Labs — Methods & Science Testing the Untestable: Our Experience Developing an Accurate Method for SR-17018 A G protein-biased opioid research compound is making its way into the analytical testing world — and most labs aren’t ready for it....
